Blog

Agilent Technologies Announces Agreement with Picometrics Technologies

Agilent Technologies Announces Agreement with Picometrics Technologies to Offer CE-LIF, CE-LIF-MS Solutions for Biopharmaceutical Applications SANTA CLARA, Calif., Jan. 16, 2014 Agilent Technologies Inc. (NYSE: A) today announced it has signed a co-marketing agreement with Picometrics Technologies to provide biopharmaceutical customers with combined solutions for capillary electrophoresis (CE), laser induced fluorescence (LIF) detection and mass spectrometry. In addition to classic CE-LIF analysis technology, this collection of tools provides the only online CELIF-MS solution available today. The platform is ideally suited for the research and development of complex large-molecule biopharmaceutical compounds. “We are very pleased to extend a long-standing and fruitful partnership with Agilent and consolidate our development strategy,” said Jean Charles Garcia, president of Picometrics. “This unique technological platform using our new-generation LIF detection will significantly increase efficiency for biotherapeutic characterization in research, development and quality control.” “We are excited to collaborate with Picometrics and provide this unique product offering to the biopharmaceutical industry-particularly those focusing on the research and development of NBEs, or new biological entities,” said Michael Frank, Agilent marketing director, liquid phase separations. “As conventional drug research becomes outmoded in meeting the increasing demands of complex, largemolecule drug development, scientists need highly sophisticated tools like these to advance therapeutic discovery.” A number of Agilent products can be combined with Picometrics ZETALIF LED and ZETALIF LASER instruments, including Agilent’s Capillary Electrophoresis and CE/MS technologies, as well as HPLC/UHPLC solutions. For more information on this combined product offering, visit Agilent’s CE-LIF solutions website. About Picometrics Picometrics Technologies, headquartered in Labege, France, is an analytical instrumentation company specializing in the manufacture and sale of a range of Laser Induced Fluorescence detectors and LEDIF (LED Induced Fluorescence) detectors commonly utilized in pharmaceutical research and development and quality control processes. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at www.agilent.com. On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.

January 16, 2014